Omeros | OMER - Dochód Netto





Dochód Netto Zmiana Data
Adma Biologics USD 49.38M 12.95M 2025-12
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Cytokinetics USD -206.03M 23M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -163.56M 164.92M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
MacroGenics USD -14.16M 30.98M 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 2.92M 1.28M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
United Therapeutics USD 274.9M 89.4M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Xoma USD -17.24M 33.23M 2024-09